Systematic review: The quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 10, 2013, Pages 937-946

  Feuerstein, J D ^a   Akbari, M ^a   Gifford, A E ^a   Cullen, G ^a   Leffler, D A ^a   Sheth, S G ^a   Cheifetz, A S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; TACROLIMUS;

CONFLICT OF INTEREST; CROHN DISEASE; ENTERITIS; EVIDENCE BASED MEDICINE; GASTROENTEROLOGY; HUMAN; INTERNATIONAL COOPERATION; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REMISSION; REVIEW; ULCERATIVE COLITIS;

CONFLICT OF INTEREST; CONSENSUS; EVIDENCE-BASED MEDICINE; GASTROENTEROLOGY; HUMANS; INFLAMMATORY BOWEL DISEASES; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL;

EID: 84876502832     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12290     Document Type: Review

References (44)

1. Institute of Medicine. Guidelines for Clinical Practice: From Development to Use. Washington, DC: The National Academies Press, 1992.
2. Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Can Med Assoc J 2010; 182: E839-42.
3. AGREE: Advancing the science of practice guidelines. Available at: http://www.agreetrust.org/. Accessed September 30, 2012.
4. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J,. Potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318: 527-30.
5. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC Jr,. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009; 301: 831-41.
6. Lee DH, Vielemeyer O,. Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. Arch Intern Med 2011; 171: 18-22.
7. Rowe IA, Parker R, Armstrong MJ, King AL, Houlihan DD, Mutimer D,. Assessment of the Quality of Evidence Underlying International Guidelines in Liver Disease. Am J Gastroenterol 2012; 107: 1276-82.
8. Jackson R, Feder G,. Guidelines for clinical guidelines: a simple, pragmatic strategy for guideline development. BMJ 1998; 317: 427.
9. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J,. Are guidelines following guidelines? JAMA 1999; 281: 1900-5.
10. Qaseem A, Forland F, Macbeth F, et al. Guidelines International Network: toward international standards for clinical practice guidelines. Ann Intern Med 2012; 156: 525-31.
11. The AGA Institute: practice recommendations development manual. Updated 2007. Available at: http://www.gastro.org/practice/medical-position-statements/ Practice-Recommendations-Manual.pdf. Accessed July 26, 2012.
12. American College of Gastroenterology: Guideline Development Policies. Available at: http://gi.org/clinical-guidelines/guideline-development-policies/. Accessed July 26, 2012.
13. British Society of Gastroenterology practice guidelines. Available at: http://www.bsg.org.uk/clinical/general/guidelines.html. Accessed September 30, 2012
14. WHO handbook for Guideline Development. Available at: http://www.who.int/hiv/topics/mtct/grc-handbook-mar2010-1.pdf. Accessed October 15, 2012.
15. Canadian Society of Gastroenterology Policies. Available at: http://www.cag-acg.org/guidelines/policies. Accessed September 30, 2012.
16. Lo B, Field MJ, Institute of Medicine (U.S.). Committee on Conflict of Interest in Medical Research Education and Practice. Conflict of interest in medical research, education, and practice. Washington, D.C.: National Academies Press, 2009.
17. Neuman J, Korenstein D, Ross JS, Keyhani S,. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ 2011; 343: 1-8.
18. Institute of Medicine (U.S.), Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Graham R,. Clinical practice guidelines we can trust. Washington, DC: National Academies Press, 2011.
19. Choudhry NK, Stelfox HT, Detsky AS,. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002; 287: 612-7.
20. Kesselheim AS, Robertson CT, Myers JA, et al. A Randomized Study of How Physicians Interpret Research Funding Disclosures. N Engl J Med 2012; 367: 1119-27.
21. Guidelines for WHO guidelines. 2003. Available at: http://whqlibdoc.who. int/hq/2003/EIP-GPE-EQC-2003-1.pdf. Accessed October 15, 2012.
22. American Gastroenterological Association: Guidelines. Available at: http://www.gastro.org/practice/medical-position-statements. Accessed July 26, 2012
23. American College of Gastroenterology: Clinical Guidelines (sortable list). Available at: http://gi.org/clinical-guidelines/clinical-guidelines- sortable-list/. Accessed July 26, 2012.
24. AGA guideline archive. Available at: http://www.gastro.org/practice/ medical-position-statements/archive. Accessed July 26, 2012
25. ECCO Guidelines. Available at: https://www.ecco-ibd.eu/publications/ecco- guidelines-publications.html. Accessed September 30, 2012.
26. Crohn's and Colitis foundation of America. Available at: www.ccfa.org. Accessed September 27, 2012.
27. Panaccione R,. Infliximab for the treatment of Crohn's disease: review and indications for clinical use in Canada. Can J Gastroenterol 2001; 15: 371.
28. Panaccione R, Fedorak RN, Aumais G, et al. Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease. Can J Gastroenterol 2004; 18: 503-8.
29. American Gastroenterological Association Clinical Practice C. American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology 2003; 125: 1503-7.
30. Jenkins D, Balsitis M, Gallivan S, et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol 1997; 50: 93-105.
31. Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010; 138: 738-45.
32. Centre for Evidence Based Medicine: Level of Evidence. Available at: http://www.cebm.net/index.aspx?o=5653. Accessed October 16, 2012.
33. Institute of Medicine. Crossing the quality chasm: A new health system for the 21st century. Washington, DC: National Academies Press, 2001.
34. Grol R,. Has guideline development gone astray? Yes. BMJ 2010; 340: c306.
35. Guidelines International Network. Available at: http://www.g-i-n.net/. Accessed October 15, 2012.
36. Mendelson TB, Meltzer M, Campbell EG, Caplan AL, Kirkpatrick JN,. Conflicts of interest in cardiovascular clinical practice guidelines. Arch Intern Med 2011; 171: 577-84.
37. National institute for health and clinical excellence: A code of practice for declaring and dealing with conflicts of interests. Available at: http://www.nice.org.uk/niceMedia/pdf/ NICECodeofPracticeConflictsofInterestApril07.pdf. Accessed September 30, 2012.
38. CMSS Code for Interactions with Companies. Available at: http://www.cmss.org/uploadedFiles/Site/CMSS-Policies/ CMSS%20Code%20for%20Interactions%20with%20Companies%20Approved%20Revised%20Vers ion%203-19-11CLEAN.pdf. Accessed September 6, 2012.
39. Steinbrook R,. Guidance for guidelines. N Engl J Med 2007; 356: 331-3.
40. Oxman A, Group GW,. Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490-4.
41. GRADE Online Learning Modules. Available at: http://cebgrade.mcmaster.ca/ . Accessed September 16, 2012.
42. Harbour R, Miller J,. A new system for grading recommendations in evidence based guidelines. BMJ 2001; 323: 334-6.
43. ECCO Guidelines. Available at: https://www.ecco-ibd.eu/science/ecco- guidelines-science.html. Accessed October 15, 2012.
44. CenterWatch: FDA Approved Drugs for Gastroenterology. Available at: http://www.centerwatch.com/drug-information/fda-approvals/drug-areas.aspx? AreaID=5. Accessed October 13, 2012.